References
- Cockburn J., Moar V. A., Ounsted M., Redman C. W.G. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982; I(8273)647
- Fidler J., Smith V., Fayers P., de Swiet M. Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. Br.Med.J. 1983; 286(6382)1927
- Gallery E. D.M., Saunders D. M., Hunyor S. N., Györy A. Z. Improvement in foetal growth with treatment of maternal hyper-ternsion in pregnancy. Clin. Science and Molecular Medicine 1978; 55: 359s
- Janssen Research Products Information Service. Clinical Research Report. 1984, Serial Number R 41468/120
- Redman C. W.G., Beilin L. J., Bonnar J. Treatment of hyper tension in pregnancy with methyldopa: blood pressure control and side effects. Br.J.Obstet.Gynaecol. 1977; 84: 419
- Redman C. W.G. A randomised comparison of methyldopa (Aldomet) and labetalol (Trandate) for the treatment of severe hypertension in pregnancy. Proc.8th. International Congress of Nephrology, Athens, 1981, and Clin. & Exper. Hyper.-Hyper, in. Pregnancy 1982; B1(2&3)345
- Rubin P. C. Beta-blockers in pregnancy. N.Engl.J.Med. 1981; 305: 1323
- Rubin P. C., Butters L., Clark D. M., Reynolds B., Summer D. J., Steedman D., Low R. A., Reid J. L. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1983; I(8322)431
- Weiner C. P., Socol M. L., Vaisrub N. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist. Am. J.Obstet.Gynecol. 1984; 149(5)496